RxDoctor Payments Data

Sierra Houston

Family · Allentown, PANPI 1609536978

Payments from drug & device makers

$642in general payments, 2019–2025

Across 12 payments — averaging $53.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$156
  • Johnson & Johnson$107
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$102
  • Boehringer Ingelheim$96
  • Boston Scientific$50
  • Abiomed$45
  • plus $85 from 3 others

What the payments were for

  • Food & beverage$642100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$642 in reported general payments places this provider in the 60th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$42,693
Medicare patients
374
Services billed
645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban197$239,412
XareltoRivaroxaban58$67,522
EntrestoSacubitril/Valsartan13$19,249
JardianceEmpagliflozin13$14,377
Metoprolol Succinate340$5,729
Atorvastatin Calcium189$2,338
Torsemide45$1,830
Rosuvastatin Calcium122$1,374
ClopidogrelClopidogrel Bisulfate78$1,336
Valsartan28$1,231
Losartan Potassium113$1,026
Metoprolol Tartrate108$1,019
Ezetimibe63$928
Isosorbide Mononitrate ErIsosorbide Mononitrate36$915
Furosemide123$908

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$107$67,52258 claims
Boehringer IngelheimJardiance$96$14,37713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,717 family providers in Pennsylvania.

Other family in Allentown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →